This illustration, created at the CDC, reveals ultrastructural morphology exhibited by the 2019 novel coronavirus, Covid-19. Credit: CDC/ Alissa Eckert, Dan Higgins.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

UK-based The Native Antigen Company has commercially introduced novel coronavirus antigens to help fight the ongoing epidemic.

The recombinant antigens were obtained from the strain, emerged in Wuhan, China, by using the company’s mammalian, VirtuE expression system.

These antigens help in infectious disease research, as well as the development of diagnostics and vaccines.

The Native Antigen Company commercial director Dr Andy Lane said: “Our mission is to reduce the global burden of infectious disease by developing the highest-quality reagents in rapid response to emerging public health threats.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“As one of the first recognised suppliers to release 2019-nCoV proteins, we are proud to be able to offer these antigens to in vitro diagnostics and pharmaceutical researchers to help drive the development of serological assays and vaccines that will be vital in stemming the spread of this disease.”

Antigens facilitate the development of serological assays to detect asymptomatic patients. They can also provide reagents to measure vaccine responses, aiding the construction of a vaccine against the virus.

Last month, researchers at the Peter Doherty Institute for Infection and Immunity in Australia recreated a lab-grown version of the new coronavirus.